Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time

JS Berg, MJ Khoury, JP Evans - Genetics in medicine, 2011 - nature.com
Technological advances often outpace our ability to effec-tively use them, a situation that
certainly could pertain to modern genomics. Breathtaking advances in genetic sequencing …

ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and …

DT Miller, K Lee, WK Chung, AS Gordon… - Genetics in …, 2021 - nature.com
Clinicians are encouraged to document the reasons for the use of a particular procedure or
test, whether or not it is in conformance with this statement. Clinicians also are advised to …

ACMG SF v3. 2 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and …

DT Miller, K Lee, NS Abul-Husn, LM Amendola… - Genetics in …, 2023 - Elsevier
Disclaimer: This statement is designed primarily as an educational resource for medical
geneticists and other clinicians to help them provide quality medical services. Adherence to …

[HTML][HTML] Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular …

S Roy, C Coldren, A Karunamurthy, NS Kip… - The Journal of Molecular …, 2018 - Elsevier
Bioinformatics pipelines are an integral component of next-generation sequencing (NGS).
Processing raw sequence data to detect genomic alterations has significant impact on …

The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic

CR Marshall, D Bick, JW Belmont, SL Taylor, E Ashley… - Genome medicine, 2020 - Springer
Clinical whole-genome sequencing (WGS) offers clear diagnostic benefits for patients with
rare disease. However, there are barriers to its widespread adoption, including a lack of …

Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing

M Allyse, M Michie - Trends in biotechnology, 2013 - cell.com
Introduction The issue of incidental findings in genomics research has been contentious,
particularly in whole genome sequencing (WGS) and whole exome sequencing (WES). An …

Advances in clinical next-generation sequencing: target enrichment and sequencing technologies

LY Ballester, R Luthra… - Expert Review of …, 2016 - Taylor & Francis
The huge parallel sequencing capabilities of next generation sequencing technologies have
made them the tools of choice to characterize genomic aberrations for research and …

Clinical sequencing: from raw data to diagnosis with lifetime value

SM Caspar, N Dubacher, AM Kopps… - Clinical …, 2018 - Wiley Online Library
High‐throughput sequencing (HTS) has revolutionized genetics by enabling the detection of
sequence variants at hitherto unprecedented large scale. Despite these advances, however …

[HTML][HTML] A rigorous interlaboratory examination of the need to confirm next-generation sequencing–detected variants with an orthogonal method in clinical genetic …

SE Lincoln, R Truty, CF Lin, JM Zook, J Paul… - The Journal of Molecular …, 2019 - Elsevier
Orthogonal confirmation of next-generation sequencing (NGS)-detected germline variants is
standard practice, although published studies have suggested that confirmation of the …

Harmonizing clinical sequencing and interpretation for the eMERGE III network

H Zouk, E Venner, NJ Lennon, DM Muzny… - The American Journal of …, 2019 - cell.com
The advancement of precision medicine requires new methods to coordinate and deliver
genetic data from heterogeneous sources to physicians and patients. The eMERGE III …